RGDXQ Stock - Response Genetics, Inc
Unlock GoAI Insights for RGDXQ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Revenue | $18.04M | $16.72M | $19.80M | $18.74M | $22.64M |
| Gross Profit | $3.94M | $6.71M | $9.35M | $8.32M | $10.91M |
| Gross Margin | 21.9% | 40.1% | 47.2% | 44.4% | 48.2% |
| Operating Income | $-21,377,000 | $-13,007,588 | $-7,945,805 | $-7,657,266 | $-5,681,853 |
| Net Income | $-20,184,000 | $-13,536,480 | $-7,479,384 | $-7,372,862 | $-5,723,140 |
| Net Margin | -111.9% | -81.0% | -37.8% | -39.3% | -25.3% |
| EPS | $-0.52 | $-0.35 | $-0.22 | $-0.28 | $-0.30 |
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Visit WebsiteEarnings History & Surprises
RGDXQEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2015 | Mar 31, 2015 | — | $-0.11 | — | — |
Q4 2014 | Dec 31, 2014 | — | $-0.09 | — | — |
Q3 2014 | Sep 30, 2014 | — | $-0.10 | — | — |
Q2 2014 | Jun 30, 2014 | — | $-0.08 | — | — |
Q2 2014 | May 8, 2014 | $-0.05 | $-0.09 | -80.0% | ✗ MISS |
Q4 2013 | Dec 31, 2013 | — | $-0.09 | — | — |
Q4 2013 | Nov 7, 2013 | $-0.07 | $-0.08 | -14.3% | ✗ MISS |
Q3 2013 | Aug 8, 2013 | $-0.04 | $-0.04 | 0.0% | = MET |
Q2 2013 | May 14, 2013 | $-0.02 | $-0.03 | -25.0% | ✗ MISS |
Q4 2012 | Dec 31, 2012 | — | $-0.01 | — | — |
Q4 2012 | Nov 13, 2012 | $-0.07 | $-0.05 | +28.6% | ✓ BEAT |
Q3 2012 | Aug 14, 2012 | $-0.12 | $-0.11 | +8.3% | ✓ BEAT |
Q2 2012 | May 10, 2012 | $-0.10 | $-0.14 | -40.0% | ✗ MISS |
Q4 2011 | Dec 31, 2011 | — | $-0.20 | — | — |
Q4 2011 | Nov 10, 2011 | $-0.02 | $-0.07 | -250.0% | ✗ MISS |
Q3 2011 | Aug 8, 2011 | $-0.00 | $-0.00 | -99.6% | ✗ MISS |
Q2 2011 | May 12, 2011 | $-0.07 | $-0.01 | +80.0% | ✓ BEAT |
Q4 2010 | Dec 31, 2010 | — | $-0.06 | — | — |
Q4 2010 | Nov 4, 2010 | $-0.11 | $-0.07 | +36.4% | ✓ BEAT |
Q3 2010 | Aug 5, 2010 | $-0.11 | $-0.02 | +81.8% | ✓ BEAT |
Latest News
Frequently Asked Questions about RGDXQ
What is RGDXQ's current stock price?
What is the analyst price target for RGDXQ?
What sector is Response Genetics, Inc in?
What is RGDXQ's market cap?
Does RGDXQ pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to RGDXQ for comparison